CHANTEL HOLZ: Open Payments
NPI 1295042075 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 11 payments from 7 companies in 2025. Trend: 2023 $174 · 2024 $57 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $206 |
| GENZYME CORPORATION | 1 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| ABBVIE INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, IQIRVO, RINVOQ, OMVOH.
Industry payments across SD — which companies pay providers there.
